← Back to Search

Implantable Device

CyPass Micro-Stent for Cataract (COMPASS XXT Trial)

N/A

Waitlist Available

Research Sponsored by Alcon Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to year 10 postoperative

Awards & highlights

COMPASS XXT Trial Summary

This trial looks at the long-term effects of the CyPass Micro-Stent on the cornea ten years after implantation.

Eligible Conditions

Cataract
Glaucoma

COMPASS XXT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to year 10 postoperative

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to year 10 postoperative

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to year 10 postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Annualized percent rate of change in Central Endothelial Cell Density at each year of observation reported by mean and 95 percent confidence interval

Annualized percent rate of change in Central Endothelial Cell Density at each year of observation reported by mean and standard deviation

Annualized rate of change in Central Endothelial Cell Density at each year of observation reported by mean and 95 percent confidence interval

+37 more

COMPASS XXT Trial Design

1Treatment groups

Experimental Treatment

Group I: CyPass Micro-StentExperimental Treatment1 Intervention

CyPass Micro-Stent placed in the angle of the eye at the conclusion of cataract surgery (COMPASS trial)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CyPass Micro-Stent

2013

N/A

~2030

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor

703 Previous Clinical Trials

124,417 Total Patients Enrolled

116 Trials studying Cataract

20,678 Patients Enrolled for Cataract

Clinical Operations Lead, SurgicalStudy DirectorAlcon Research, LLC

1 Previous Clinical Trials

124 Total Patients Enrolled

1 Trials studying Cataract

124 Patients Enrolled for Cataract

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the opportunity for participation in this experiment currently available to volunteers?

"Affirmative. A perusal of the information on clinicaltrials.gov reveals that enrollment for this experiment, which was originally posted on December 21st 2020, is still open. The trial requires 374 participants from 3 different sites to be fully recruited."

Answered by AI

How many individuals are participating in the research project?

"Affirmative. According to clinicaltrials.gov, the trial is still recruiting participants and was first posted on December 21st 2020 with a last edit date of May 2nd 2022. 374 patients need to be enrolled from 3 different locations in order for the research to proceed as intended."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent

2020. "Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04629521.